Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 HKD | 0.00% | +14.38% | -9.09% |
Apr. 26 | CSPC Pharmaceutical Group Limited Announces Highly Selective Mat2A Inhibitor Obtains Clinical Trial Approval in the U.S | CI |
Apr. 24 | CSPC Pharmaceutical's EBT Buys 8.5 Million Shares | MT |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- MarketScreener Strategies